Physician profile
Selima Hadad
NPI 1659415511
$5,757.53
in general payments reported to CMS, 2019-2025
7 companies · $1,540 in 2025
The $1,540 reported for 2025 was more than what 97% of General Practice (Dentist) providers received nationally (typical 2025 total: $74.60).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $711 · 2020: $11.44 · 2022: $501 · 2023: $1,983 · 2024: $1,012 · 2025: $1,540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,840 · Travel and Lodging: $1,121 · Entertainment: $750 · Education: $538 · Gift: $285.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,840.09 |
| Travel and Lodging | $1,121.47 |
| Entertainment | $750.00 |
| Education | $537.50 |
| Gift | $285.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dentsply Sirona INC | $2,468.50 | 2023-2024 | |
| Zimvie INC. | $2,311.52 | 2022-2025 | |
| Zimmer Biomet Holdings, INC. | $710.82 | 2019 | |
| Ultradent Products INC | $217.25 | 2023 | Opalescence |
| Patterson Companies, INC. | $19.25 | 2024 | |
| Solventum Corporation | $18.75 | 2024 | 3m Filtek, 3m Relyx, 3m Scotchbond |
| Philips North America LLC | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selima Hadad listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.